Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (28) clinical trials

Patient Inclusion Criteria: Ages: over 55-90 Male/Female 12 Month Long Clinical Trial MMSE score 24-30/20-26 Subjects must meet criteria for Prodromal AD or Mild AD: Mini Mental State Examination (MMSE) score between 20-30 Clinical Dementia Rating Scale (CDR) score of 0.5 or 1 a free recall score of lesser or ...

Phase

If you qualify, the study may involve 4 in-clinic stays,2 outpatient visits, and 1 telephone follow up. The in-clinic stays will consist of 3 days and 2 nights. You do not need medical insurance to participate in this research study.

Phase

If you qualify, the study may involve 3 screening visits, 1 separate in-clinic stay of 5 days/4 nights and 10 outpatient visits. All study exams and procedures are provided at no cost to you. You do not need medical insurance to participate.

Phase

This study will evaluate the safety and efficacy of NPT088 or Placebo in participants with probable Alzheimer's Disease

Phase

This clinical trial is provided by Antidote. Test

Phase

The PAREXEL® Early Phase Unit located in Glendale, CA is currently looking for people who have been diagnosed with Mild Cognitive Impairment (MCI) or Alzheimer’s disease to participate in a clinical research study that will evaluate an investigational medication for Alzheimer’s disease.

Phase

Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart

A growing body of evidence suggests that insulin plays a role in normal memory processes and that insulin abnormalities may contribute to cognitive and brain changes associated with Alzheimer's disease (AD). Interestingly, insulin administered to the nasal cavity is transported within a few minutes into the brain, but does not ...

Phase

Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients With Alzheimer's Disease

This is a randomized, placebo-controlled clinical trial designed to evaluate the safety and efficacy of LMSCs (Longeveron Mesenchymal Stem Cells) or placebo in subjects with Alzheimer's Disease. Following a successful Safety Run-In Phase, a total of twenty-five (25) subjects will be randomized to (2:2:1) to receive low-dose LMSCs, high-dose LMSCs ...

Phase